In 2017, a Nature paper got a lot of attention due to the claim by the Stanford authors that the CRISPR-based gene editing technique may cause widespread genetic damage when used in vivo. The authors have just retracted this paper, after concerns were raised that the proper controls had not been employed.
23andMe CEO Anne Wojcicki has published an Op-ed critique of the position that consumers cannot interpret their own genetic risk scores. Recently, the FDA approved 23andMe’s genetic test for inherited cancer. There was some criticism of this, which Wojcicki compares to the warnings forty years ago that women might not be able to handle the results of those first home pregnancy tests.
Check out our conference page for updates from Canada SynBio 2018 including presentations, highlights and photos from the conference.
-Conference Presentations can be found by clicking on the active links under each session in the SynBio Agenda.
-Conference Highlights can be found in our SynBio Feature.
-Additional Photos from the conference can be found in our SynBio Page and Photo Album.
Major advances in genomics and informatics over the past several years have resulted in individual research projects producing enormous amounts of data. In particular, genomic data from large population and clinical cohorts, coupled with extensive health and lifestyle data, have the potential to generate critical biological insights into human health and novel determinants of disease….
Ontario’s diverse agriculture, agri-food and aquaculture sectors are the focus of three new funding opportunities. All of these new project funding opportunities require partnering researchers together with end-users in their respective sectors. We work directly with researchers, and end-users to: access funding find and connect with the right research and/or end-user partners help develop competitive…
Ontario Genomics (OG) is looking for a Summer Student, who will be a key contributor to our Business Development and Research Programs teams. The Knowledge Translation Intern will be responsible for sourcing data and putting together compelling stories about research and commercialization to be communicated to our stakeholders in academia, government and industry.
Ontario Genomics is looking for a summer student to provide support to the Business Development Group. The Business Intern will work to deliver specific reports for the Business Development team (e.g. diagnoses of the environment and competitive situation in a given sector, scans to identify high-level lines of opportunities that OG is well-positioned to make an impact on etc.).
The Database Clerk is responsible for the routine maintenance and management of the organization’s contact management system and other key data sources. The role will require strong analytical, interpersonal, organizational and communications skills. A flexible and positive attitude towards the changing dynamics of the Ontario Genomics environment is an asset.
Deadline for applications is April 30, 2018.
Genome Canada has partnered with the Canadian Institutes of Health Research (CIHR) to launch a funding opportunity to support a national network that will help maintain Canada’s leadership in enabling clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function, and to develop…
Richard Beauchamp is cancer free despite his pancreatic cancer diagnosis in 2014. Beauchamp learned that, in his case, his French Canadian genes held a clue to an effective treatment when he enrolled in the pan-Canadian clinial trial EPPIC. EPPIC aims to sequence the tumours of pancreatic cancer patients across the country and provide personalized treatment based on their particular subtype of the disease. Beauchamp and others are seeing the benefits of this approach.